A unit of AstraZeneca Plc is facing a new antitrust suit claiming the company monopolized the market for a blood disorder ...

AstraZeneca PLC closed 24.38% short of its 52-week high of £133.88, which the company reached on September 3rd.

With biosimilars to AstraZeneca’s blockbuster rare blood disease med Soliris recently available in the U.S., nonprofit health ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

We recently published a list of 10 Best UK Stocks to Buy According to Billionaires. In this article, we are going to take a ...

Now may be an ideal time to buy stocks. Even if you don't have a lot of money that you can afford to invest, there are many ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Financial Health for AstraZeneca DRC is determined by ranking the company on over 100 factors against companies in the Healthcare sector and operating in Developed economic markets. Loading view ...

Please visit astrazeneca.com and follow the Company on social media @AstraZeneca. 22nd May 2014 10:42 am RNS Form 8.5 (EPT/RI) Astrazeneca Plc 22nd May 2014 10:41 am RNS Form 8.5 (EPT/RI ...

In accordance with the Company's Articles of Association ... Amendment 22nd May 2014 3:53 pm RNS Form 8.3 - AstraZeneca PLC 22nd May 2014 3:48 pm RNS Form 8.3 - Pfizer Inc 22nd May 2014 3:22 ...